We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,953.00
Bid: 6,953.00
Ask: 6,955.00
Change: -57.00 (-0.81%)
Spread: 2.00 (0.03%)
Open: 7,001.00
High: 7,172.00
Low: 6,943.00
Yest. Close: 7,010.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LONDON MARKET PRE-OPEN: Glaxo Gets Positive Results From Zejula Study

(Alliance News) - Stock prices in London are seen opening slightly higher on Monday, tracking gains in Chinese equity markets despite a reported slowdown in economic growth there.In early UK news,

15 Jul 19 07:40

TOP NEWS: AstraZeneca Gets US FDA Orphan Drug Designation For Imfinzi

(Alliance News) - AstraZeneca PLC on Friday said it has secured Orphan Drug Designation for small cell lung cancer treatment Imfinzi from the US Food & Drug Administration.The FDA Drug

12 Jul 19 08:56

AstraZeneca Gets Positive EU Committee Opinion On Forixga And Fasenra

(Alliance News) - AstraZeneca PLC on Monday said it has received positive opinions in the EU for drugs Forixga and Fasenra.The European Medicines Agency's Committee for Medicinal for EU

1 Jul 19 08:56

Thursday broker round-up

(Sharecast News) - Rightmove: UBS downgrades to sell with a target price of 505p.

27 Jun 19 11:16

Encouraging Interim Analysis From Trial Of AstraZeneca Drug Imfinzi

(Alliance News) - AstraZeneca PLC on Thursday said interim analysis of its Caspian trial of Imfinzi showed the drug improved overall survival in extensive-stage small cell lung analysis of the had

27 Jun 19 10:55

AstraZeneca reveals positive overall survival results from Imfinzi trial

(Sharecast News) - Biopharmaceutical company AstraZeneca revealed some positive overall survival results from its Phase III CASPIAN trial with Imfinzi, a human monoclonal antibody.

27 Jun 19 08:28

TOP NEWS: AstraZeneca's Breztri Aerosphere, Lynparza Approved In Japan

(Alliance News) - AstraZeneca PLC on Wednesday announced drug approvals in Japan, including Lynparza for advanced ovarian cancer and Breztri Aerosphere for chronic obstructive pulmonary Aerosphere

19 Jun 19 08:30

LONDON MARKET PRE-OPEN: Whitbread Sales Down; Berkeley Profit Slips

(Alliance News) - Stocks in London on Wednesday are set to build on the previous session's gains as traders await the latest decision from the US Federal Reserve in the wake of dovish comments

19 Jun 19 07:47

AstraZeneca gets three new drug approvals in Japan

(Sharecast News) - AstraZeneca announced three new drug approvals in Japan on Wednesday, with the first for 'Breztri Aerosphere' (budesonide/glycopyrronium/ formoterol fumarate) - formerly PT010 - as a triple-combination therapy to relieve symptoms of chronic obstructive pulmonary disease (COPD).

19 Jun 19 07:29

LONDON MARKET CLOSE: Dovish Draghi Sparks Off Rally Across Europe

(Alliance News) - An unremarkable start to the day for London stocks picked up mid-morning as dovish comments from European Central Bank President Mario Draghi boosted equities across Europe. - is

18 Jun 19 16:59

LONDON MARKET MIDDAY: Dovish ECB Draghi Gives Stocks Helping Hand

(Alliance News) - Seemingly not wanting to be left out in a week that features policy meetings of the US Federal Reserve and the Bank of England, the head of the European Central Bank was the of a

18 Jun 19 11:51

WINNERS & LOSERS SUMMARY: Telecom Plus Up On Strong Earnings, Outlook

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Ashtead,

18 Jun 19 10:23

LONDON MARKET OPEN: Ashtead Rises On Strong Earnings And Buyback Plans

(Alliance News) - Stock prices in London opened flat on Tuesday, with Ashtead rising after strong annual results, helping the FTSE 100 to outperform other European indices.The UK

18 Jun 19 08:49

AstraZeneca secures another European indication for 'Lynparza'

(Sharecast News) - AstraZeneca and its partner MSD announced on Tuesday that the European Commission (EC) has approved 'Lynparza' (olaparib) as a first-line maintenance treatment for women with BRCA-mutated advanced ovarian cancer.

18 Jun 19 07:28

AstraZeneca upbeat on latest 'Calquence' trial data

(Sharecast News) - AstraZeneca announced detailed results from the interim analysis of the phase 3 'ASCEND' trial on Monday, showing Calquence (acalabrutinib) significantly prolonged the time patients lived without disease progression in relapsed or refractory chronic lymphocytic leukaemia (CLL).

17 Jun 19 07:24

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.